NCT04957550Active, not recruitingPhase 3
To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Clinical Study to Evaluate the Efficacy and Safety of SHR0302 in Active Psoriatic Arthritis Subjects
Source: ClinicalTrials.gov · Last updated 28 Aug 2026
Brief summary (registry, in English)
This study is a phase 3 study,to evaluate the efficacy and safety of different doses of JAK1 inhibitor SHR0302 in subjects with active psoriatic arthritis.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 418 (actual)
- First submitted
- 5 Jul 2021
- Start date
- 30 Aug 2021
- Primary completion date
- 13 Dec 2026
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Diseases
- Psoriasis, Psoriatic arthritis
- NCT number
- NCT04957550
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 418
- From 30 Aug 2021 to the primary completion date, 13 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous treatment with cytotoxic drugs; JAK inhibitor or bDMARDs within 6 months of randomization.
Other illness
- History of other autoimmune diseases; history of cancer or infection including tuberculosis and hepatitis; history of important cardiovascular events or thrombotic diseases；
Other
- Non-plaque forms of psoriasis (with exception of nail psoriasis)；
Who the study is looking for
- Provide signed informed consent；
- Diagnosis of PsA fulfillment of the Classification Criteria for PsA (CASPAR) criteria with symptom onset at least 6 months prior to the Screening Visit；
- Active arthritis at screening/baseline as indicated by \>/= 3 tender/painful and 3 swollen joints；
- Diagnosis of active plaque psoriasis or documented history of plaque psoriasis.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.